Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy-Reference-Cited by-同舟云学术

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy

Author:

Deng Min¹²,Li Shaohua¹²,Wang Qiaoxuan²³,Zhao Rongce¹²,Zou Jingwen¹²,Lin Wenping¹²,Mei Jie¹²,Wei Wei¹²,Guo Rongping¹²

Affiliation:

1. Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China

2. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

3. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Science and Technology Planning Project of Guangdong Province

Science and Technology Planning Project of Guangzhou

Clinical Trials Project [5010 Project] of Sun Yat-sen University

Clinical Trials Project [308 Project] of Sun Yat-sen University Cancer Centre

Medical Innovation Project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine

Publisher

Informa UK Limited

Subject

General Medicine

Link

Reference48 articles.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献